Gram Negatif Bakteriyel Enfeksiyonlar

Burns, R. E., Wagner, D.C., Leutenegger, C.M., Pesa- vento, P.A. (2011). Histologic and molecular correlati- on in shelter cats with acute upper respiratory infecti- on. Journal of clinical microbiology, 49(7), 2454-2460.

Belcher KL, Wise DJ, Veit HP.(2000). Canine coloniza- tion and transmission of Bordetella pertussis. Annals NY Acad Sci.:687–690.

Belcher, K. L., Wise, D. J., Veit, H. P. (2000). Canine colonization and transmission of Bordetella pertussis. Annals of the New York Academy of Sciences, 916(1): 687-690.

Bentley, A. M., Mayhew, P. D., Culp, W. T., Otto, C. M. (2013). Alterations in the hemostatic profiles of dogs with naturally occurring septic peritonitis. Journal of Veterinary Emergency and Critical Care. 23(1), 14-22.

Binns, S. H., Dawson, S., Speakman, A. J., Cuevas, L. E., Gaskell, C. J., Hart, C. A., Gaskell, R.M. (1999). Preva- lence and risk factors for feline Bordetella bronchisep- tica infection. Veterinary Record, 144(21), 575-580.

Boothe, D.M., Boeckh, A., Simpson, R. B., Dubose, K. (2006). Comparison of pharmacodynamic and phar- macokinetic indices of efficacy for 5 fluoroquinolones toward pathogens of dogs and cats. Journal of veteri- nary internal medicine, 20(6), 1297-1306.

Brachelente, C., Wiener, D., Malik, Y., Huessy, D. (2007). A case of necrotizing fasciitis with septic shock in a cat caused by Acinetobacter baumannii. Veterinary dermatology, 18(6), 432-438.

Bradley, A., Kinyon, J., Frana, T., Bolte, D., Hyatt, D. R., Lappin, M.R. (2012). Efficacy of intranasal administration of a modified live feline herpesvirus 1 and feline calicivirus vaccine against disease caused by Bordetella bronchiseptica after experimental challenge. Journal of Veterinary Internal Medicine, 26(5), 1121-1125.

Byrd, L. H., Anama, L., Gutkin, M, Chmel, H. (1981).

Bordetella bronchiseptica peritonitis associated with continuous ambulatory peritoneal dialysis. Journal of Clinical Microbiology, 14(2), 232-233.

Clements, J., McGrath, C., McAllister, C. (2018). Bordetella bronchiseptica pneumonia: beware of the dog!. Case Reports, 2018, bcr-2018.

Dawson, S., Jones, D., McCracken, C. M., Gaskell, R. M., Hart, C. A., Gaskell, C. J. (2000). Bordetella bronchiseptica infection in cats following contact with infected dogs. The Veterinary Record, 146(2): 46-48.

Day, M. J., Carey, S., Clercx, C., Kohn, B., MarsilIo, F., Thiry, E., Walker, D.J. (2020). Aetiology of canine infectious

respiratory disease complex and prevalence of its pathogens in Europe. Journal of comparative pathology, 176, 86-108.

Diavatopoulos, D. A., Cummings, C. A., Schouls, L. M., Brinig, M. M., Relman, D. A., & Mooi, F. R. (2005).

Bordetella pertussis, the causative agent of whoopingcough, evolved from a distinct, human-associated lineage of B. bronchiseptica. PLoS pathogens 1: 0373–0383.

Endimiani, A., Hujer, K. M., Hujer, A. M., Bertschy, I., Rossano, A., Koch, C., Perreten, V. (2011). Acinetobacter baumannii isolates from pets and horses in Switzerland: molecular characterization and clinical data. Journal of antimicrobial chemotherapy, 66(10), 2248-2254.

Francey, T., Gaschen, F., Nicolet, J., & Burnens, A. P. (2000). The role of Acinetobacter baumannii as a nosocomial pathogen for dogs and cats in an intensive care unit. Journal of Veterinary Internal Medicine, 14(2), 177-183.

Gisel JJ, Brumble LM, Johnson MM (2010). Bordetella bronchiseptica pneumonia in a kidney-pancreas transplant patient after exposure to recently vacci- nated dogs: case report. Transplant Infect Disease. 12: 73–76

Gross R, Keidel K, Schmitt K. Resemblance and divergence: the “new” members of the genus Bordetella. Med Microbiol Immunol. 2010;199: 155–163.

Hadley, K., Torres, A. M., Moran, J., Schiller, B. (2009). Bordetella bronchiseptica peritonitis—beware of the dog!. Peritoneal Dialysis International, 29(6), 670-671.

Huebner, E. S., Christman, B., Dummer, S., Tang, Y. W., Goodman, S. (2006). Hospital-acquired Bordetella bronchiseptica infection following hematopoietic stem cell transplantation. Journal of Clinical Microbiology, 44(7), 2581-2583.

Inatsuka, C. S., Xu, Q., Vujkovic-Cvijin, I., Wong, S., Stibitz, S., Miller, J. F., Cotter, P. A. (2010). Pertactin is required for Bordetella species to resist neutrophil-mediated clearance. Infection and immunity, 78(7), 2901-2909.

Jenkins, S. G. (2001). Infections due to anaerobic bacteria and the role of antimicrobial susceptibility testing of anaerobes. Reviews and Research in Medical Microbiology, 12(1), 1-12.

Kidsley, A. K., O’Dea, M., Saputra, S., Jordan, D., Johnson, J. R., Gordon, D. M., Trott, D. J. (2020). Genomic analysis of phylogenetic group B2 extraintestinal pathogenic E. coli causing infections in dogs in Australia. Veterinary Microbiology, 248, 108783.

Kidsley, A. K., White, R. T., Beatson, S. A., Saputra, S., Schembri, M. A., Gordon, D., Trott, D. J. (2020).

Companion animals are spillover hosts of the multidrug-resistant human extraintestinal Escherichia coli pandemic clones ST131 and ST1193. Frontiers in microbiology, 11, 1968.

Kristinsson, G. (2007). Pasteurella multocida infections. Pediatrics in Review, 28(12): 472-473.

Maboni, G., Seguel, M., Lorton, A., Berghaus, R., Sanchez, S. (2019). Canine infectious respiratory disease: new insights into the etiology and epidemiology of associated pathogens. PloS one, 14(4), e0215817.

Marks, S. L., Rankin, S. C., Byrne, B. A., Weese, J. S.(2011). Enteropathogenic bacteria in dogs and cats: diagnosis, epidemiology, treatment, and control. Journal of veterinary internal medicine, 25(6), 1195-1208.

Mattoo S, Cherry JD. (2005).Molecular pathogenesis, epidemiology, and clinical manifestations of respiratoryinfections due to Bordetella pertussis and other Bordetella subspecies. Clin Microbiol Rev. 18:326–382.

Moon, B. Y., Ali, M. S., Kwon, D. H., Heo, Y. E., Hwang, Y. J., Kim, J. I., Lim, S. K. (2023). Antimicrobial resistance in Escherichia coli isolated from healthy dogs and cats in South Korea, 2020–2022. Antibiotics, 13(1):27.

Morgane Canonne, A., Roels, E., Menard, M., Desquilbet, L., Billen, F., Clercx, C. (2020). Clinical response to 2 protocols of aerosolized gentamicin in 46 dogs with Bordetella bronchiseptica infection (2012‐2018). Journal of Veterinary Internal Medicine, 34(5), 2078-2085.

Parkhill J, Sebaihia M, Preston A, et al. Comparative analysis of the genome sequences of Bordetella pertussis, Bordetella parapertussis and Bordetella bronchiseptica.Nat Genet. 2003;35:32–40.

Rzewuska, M., Czopowicz, M., Kizerwetter-Świda, M., Chrobak, D., Błaszczak, B., & Binek, M. (2015). Multidrug resistance in Escherichia coli strains isolated from infections in dogs and cats in Poland (2007–2013). The Scientific World Journal, 1: , 408205.

Sanchez Jr, C. J., Mende, K., Beckius, M. L., Akers, K. S., Romano, D. R., Wenke, J. C., & Murray, C. K. (2013).

Biofilm formation by clinical isolates and the implications in chronic infections. BMC infectious diseases, 13(1), 47.

Schulz, B. S., Kurz, S., Weber, K., Balzer, H. J., Hartmann, K. (2014). Detection of respiratory viruses and Bordetella bronchiseptica in dogs with acute respiratory tract infections. The Veterinary Journal, 201(3), 365-369.

Scott-Garrard MM, Chiang YW, David F. Comparative onset of immunity of oral and intranasal vaccines against challenge with Bordetella bronchiseptica. Vet RecOpen. 2018;5:e000285.

Speakman, A. J., Dawson, S., Corkill, J. E., Binns, S. H., Hart, C. A., Gaskell, R. M. (2000). Antibiotic susceptibility of canine Bordetella bronchiseptica isolates. Veterinary Microbiology, 71(3-4), 193-200.

Sugino, Y., Kato, M., Yagi, A., & Kawabata, A. (2007).

Pasteurella multocida pneumonia with molecular evidence of zoonotic transmission. Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases, 81(6), 726-730.

Toshach K, Jackson MW, Dubielzig RR. Hepatocellular necrosis associated with the subcutaneous injection of an intranasal Bordetella bronchiseptica- canine parainfluenza vaccine. J Am Anim Hosp Assoc. 1997;33:126–128.

Walter, J., Foley, P., Yason, C., Vanderstichel, R., Muckle, A. (2020). Prevalence of feline herpesvirus-1, feline calicivirus, Chlamydia felis, and Bordetella bronchiseptica in a population of shelter cats on Prince EdwardIsland. Canadian Journal of Veterinary Research, 84(3), 181-188.

Weese, J. S., Blondeau, J. M., Boothe, D., Breitschwerdt, E. B., Guardabassi, L., Hillier, A., Sykes, J. E. (2011).

Antimicrobial use guidelines for treatment of urinary tract disease in dogs and cats: antimicrobial guidelines working group of the international society for companion animal infectious diseases. Veterinary Medicine International. 1: 263768.

Wei, B., Liu, C., Zhu, J., Zou, X., Zhang, Z. (2025). Pasteurella multocida infection: a differential retrospectivestudy of 482 cases of P. multocida infection in patient of different ages. BMC Infectious Diseases, 25(1), 313.

Wernli, D., Emonet, S., Schrenzel, J., Harbarth, S. (2011). Evaluation of eight cases of confirmed Bordetella bronchiseptica infection and colonization over a 15‐year period. Clinical Microbiology and Infection, 17(2), 201-203.

Williams, J., Laris, R., Gray, A.W., Jacobs, A. A. C. (2002). Studies of the efficacy of a novel intranasal vaccine against feline bordetellosis. Veterinary record, 150(14), 439-442.

Woolfrey, B. F., Moody, J.A. (1991). Human infections associated with Bordetella bronchiseptica. Clinical Microbiology Reviews, 4(3), 243-255.

Zordan, S., Prenger-Berninghoff, E., Weiss, R., Van der Reijden, T., Van den Broek, P., Baljer, G., Dijkshoorn, L.(2011). Multidrug-resistant Acinetobacter baumannii in veterinary clinics. Germany. Emerg Infect Dis.17: 1751–1754.